Publications by authors named "Eva Bandres"

Claim this Profile
I
Identification of a Novel HLA-C Allele With a New Amino Acid Residue in the α-3 Domain, HLA-C*07:1216.
Judith Olleta, Maria Jesus Gil, Eva Bandres

HLA· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the novel HLA-DQA1*01:133Q allele with one amino acid deletion in the alpha-3 domain.
Eva Bandres, Maria Jesus Gil, Judith Olleta, Antonio Balas, Jose L Vicario

HLA· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potency assessment of IFNγ-producing SARS-CoV-2-specific T cells from COVID-19 convalescent subjects.
Rubén Gil-Bescós, Ainhoa Ostiz, Saioa Zalba, Ibai Tamayo, Eva Bandrés

Life Sci Alliance· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Geographical distribution of risk genotypes in pediatric patients with celiac disease in Spain".
Félix Sánchez-Valverde, Eva Martínez-Ojinaga, Ester Donat, Andrés Bodas, Eva Bandrés

Hum Immunol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of two HLA-C alleles with new amino acid residues in the α-3 domain, HLA-C*03:581 and -C*05:267.
Eva Bandres, Patricia Arnedo, Axier Jauregui, Antonio Balas, Jose L Vicario

HLA· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic Regulation of microRNAs in Cancer: Shortening the Distance from Bench to Bedside.
María J Pajares, Ester Alemany-Cosme, Saioa Goñi, Eva Bandres, Cora Palanca-Ballester

Int J Mol Sci· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET.
Marc Garcia-Moure, Marisol Gonzalez-Huarriz, Sara Labiano, Elizabeth Guruceaga, Eva Bandres

Clin Cancer Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms.
Paula Aguirre-Ruiz, Beñat Ariceta, María Cruz Viguria, María Teresa Zudaire, Zuriñe Blasco-Iturri

J Clin Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression.
Ascensión López-Díaz de Cerio, Ricardo García-Muñoz, Esther Pena, Ángel Panizo, Jesús Feliu

Br J Haematol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional specific-T-cell expansion after first cytomegalovirus reactivation predicts viremia control in allogeneic hematopoietic stem cell transplant recipients.
Miriam Ciáurriz, Lorea Beloki, Amaya Zabalza, Eva Bandrés, Cristina Mansilla

Transpl Infect Dis· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance of the transcriptional signature regulated by CDC42 in colorectal cancer.
Fatima Valdés-Mora, Warwick J Locke, Eva Bandrés, David Gallego-Ortega, Paloma Cejas

Oncotarget· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Streptamer technology allows accurate and specific detection of CMV-specific HLA-A*02 CD8 T cells by flow cytometry.
Miriam Ciáurriz, Lorea Beloki, Eva Bandrés, Cristina Mansilla, Amaya Zabalza

Cytometry B Clin Cytom· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients.
Miriam Ciáurriz, Amaya Zabalza, Lorea Beloki, Cristina Mansilla, Estela Pérez-Valderrama

Cell Mol Life Sci· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiRNAs and LincRNAs: Could they be considered as biomarkers in colorectal cancer?
Ruth Zarate, Valentina Boni, Eva Bandres, Jesús Garcia-Foncillas

Int J Mol Sci· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization.
Karmele Valencia, Diego Luis-Ravelo, Nicolas Bovy, Iker Antón, Susana Martínez-Canarias

Mol Oncol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of T cell selection methods in the success of clinical adoptive immunotherapy.
Natalia Ramírez, Lorea Beloki, Miriam Ciaúrriz, Mercedes Rodríguez-Calvillo, David Escors

Cell Mol Life Sci· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The abrogation of TCR-independent interactions with human serum ensures a selective capture of therapeutic virus-specific CD8+ T-cells by multimer technology in Adoptive Immunotherapy.
Lorea Beloki, Miriam Ciáurriz, Cristina Mansilla, Eva Bandrés, Mercedes Rodríguez-Calvillo

J Immunol Methods· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-326 associates with biochemical markers of bone turnover in lung cancer bone metastasis.
Karmele Valencia, Marta Martín-Fernández, Carolina Zandueta, Cristina Ormazábal, Susana Martínez-Canarias

Bone· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer.
Javier Rodríguez, Ruth Zarate, Eva Bandres, Valentina Boni, Amaia Hernández

Eur J Cancer· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas.
Marta M Alonso, Ricardo Diez-Valle, Lorea Manterola, Angel Rubio, Dan Liu

PLoS One· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array.
Ana Abajo, Nerea Bitarte, Ruth Zarate, Valentina Boni, Ines Lopez, Eva Bandres

World J Gastroenterol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells.
Nerea Bitarte, Eva Bandres, Valentina Boni, Ruth Zarate, Javier Rodriguez

Stem Cells· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of steroid and xenobiotic receptor (SXR) and multidrug resistance 1 (MDR1) gene expression with survival among patients with invasive bladder carcinoma.
Jorge Rioja, Eva Bandrés, David Rosell Costa, Anibal Rincón, Ines López

BJU Int· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer.
Alfons Navarro, Tania Diaz, Elena Gallardo, Nuria Viñolas, Ramon M Marrades, Eva Bandres

J Surg Oncol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation.
Valentina Boni, Nerea Bitarte, Ion Cristobal, Ruth Zarate, Javier Rodriguez, Eva Bandres

Mol Cancer Ther· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis